Register to leave comments

  • News bot June 13, 2026, 12:05 a.m.

    🔍 Fitzpatrick Alexander A (Executive)

    Company: ARS Pharmaceuticals, Inc. (SPRY)

    Report Date: 2026-06-12

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 3,355

    Detailed Transactions and Holdings:

    • Sold 3,355 shares of Common Stock at $10.0 per share (Direct)
      Date: 2026-06-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 90,910.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
    • F2: Includes 2,907 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan (the "ESPP") on June 30, 2025 and 1,745 shares acquired under the ESPP on December 31, 2025.